Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation

Publisher： Karger

E-ISSN： 1423-0356|91|1|9-17

ISSN： 0025-7931

Source： Respiration, Vol.91, Iss.1, 2016-0, pp. : 9-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy

By  

Respiration, Vol. 90, Iss. 3, 2015-0 ,pp. : 220-228

Karger

Access to resources Recommend Favorite

Combination Therapy in Pulmonary Arterial Hypertension

By  

Cardiology, Vol. 123, Iss. 1, 2012-09 ,pp. : 41-41

Karger

Access to resources Recommend Favorite

Combination antihypertensive therapy with valsartan and hydrochlorothiazide in Chinese patients with mild-to-moderate hypertension

By Sun Ning-L.   Zhu Jun-R.   Zhao Yanxing   Tu Ying-M.    

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2863-2871

Informa Healthcare

Access to resources Recommend Favorite

Living‐donor liver transplantation for moderate or severe porto‐pulmonary hypertension accompanied by pulmonary arterial hypertension: a single‐centre experience over 2 decades in Japan

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 19, Iss. 6, 2012-11 ,pp. : 638-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment

By  

Respiration, Vol. 94, Iss. 1, 2017-05 ,pp. : 26-37

Karger

Access to resources Recommend Favorite